CA9 and neoplasm: The analysis showed that 134 (85%) patients had a negative, weak or moderate CAIX protein content (immunoreactive score (IRS) 0–6) in the tumor and only 24 (15%) of the patients had a strong expression for CAIX (IRS 8–12) in the tumor tissue.